Dextran of Diverse Molecular-Configurations Used as a Blood-Plasma Substitute, Drug-Delivery Vehicle and Food Additive Biosynthesized by Leuconostoc, Lactobacillus and Weissella
Source abstract
Abstract
Dextran, a microbial metabolite of diverse molecular configurations, can be biosynthesized employing selected strains of characterized species of bacteria. Dextran molecules are secreted as an extracellular polysaccharide in the culture medium of the bacterial fermentation system. This microbially produced polymer of glucose possesses multi-faceted characteristics such as its solubility in different solvents and formation of dextran solutions of needed viscosity. Several preparations can be formulated for the desired thermal and rheological properties. Due to such multifunctional characteristics, dextran with different structural specifications is a desired polysaccharide for clinical, pharmaceutical, and food industry commercial applications. Dextran and its derivative products with various molecular weights, in a range of high and low, have established their uses in drug delivery and in analytical devices using columns packed with polysaccharide gel. Therefore, being a neutral raw material, the resourcefulness of dextran preparations of different molecular weights and linkages in their polymer configuration is important. For this purpose, several studies have been performed to produce this commercially important polysaccharide under optimized bacterial cultivation processes. This article aims to overview recently published research reports on some significant applications of dextran in the pharmaceutical and food industries. Studies conducted under optimized conditions in fermentation processes for the biosynthesis of dextran of diverse molecular configurations, which are responsible for its multifunctional properties, have been summarized. Concise information has been presented in three separate tables for each group of specific bacterial species employed to obtain this extracellular microbial polysaccharide.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Probiotics and Fermented Foods · Enzyme Production and Characterization · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Wexham Park Hospital, Wexham Street, Slough Berkshire SL2 4HL, UK
Biomedical Sciences Research Institute, Ulster University, Coleraine BT52 1SA, UK
References (100+)
Show source-provided references
1. Dahiya, D., and Nigam, P.S. (2022). The Gut Microbiota Influenced by the Intake of Probiotics and Functional Foods with Prebiotics Can Sustain Wellness and Alleviate Certain Ailments like Gut-Inflammation and Colon-Cancer. Microorganisms, 10.10.3390/microorganisms10030665 ↗
2. Dahiya, D., and Nigam, P.S. (2023). Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer. Int. J. Mol. Sci., 24.10.3390/ijms24065748 ↗
3. Ganatsios, V., Nigam, P.S., Plessas, S., and Terpou, A. (2021). Kefir as a Functional Beverage Gaining Momentum towards Its Health Promoting Attributes. Beverages, 7.10.3390/beverages7030048 ↗
4. Dahiya, D., and Nigam, P.S. (2023). Therapeutic and Dietary Support for Gastrointestinal Tract Using Kefir as a Nutraceutical Beverage: Dairy-Milk-Based or Plant-Sourced Kefir Probiotic Products for Vegan and Lactose-Intolerant Populations. Fermentation, 9.10.3390/fermentation9040388 ↗
5. Dahiya, D., and Nigam, P.S. (2023). Nutraceuticals Prepared with Specific Strains of Probiotics for Supplementing Gut Microbiota in Hosts Allergic to Certain Foods or Their Additives. Nutrients, 15.10.3390/nu15132979 ↗
6. Dahiya, D., and Nigam, P.S. (2023). Use of Characterized Microorganisms in Fermentation of Non-Dairy-Based Substrates to Produce Probiotic Food for Gut-Health and Nutrition. Ferment. Sect. Ferment. Food Beverages, 9.10.3390/fermentation9010001 ↗
7. Dahiya, D., and Nigam, P.S. (2022). Nutrition and Health through the Use of Probiotic Strains in Fermentation to Produce Non-Dairy Functional Beverage Products Supporting Gut Microbiota. Foods, 11.10.3390/foods11182760 ↗
8. Natural exopolysaccharides as novel excipients in drug delivery: A review
9. Determination of structural peculiarities of dextran, pullulan and γ-irradiated pullulan by Fourier-transform IR spectroscopy10.1016/S0008-6215(02)00209-4 ↗
10. Green preparation process, characterization and antitumor effects of doxorubicin–BSA–dextran nanoparticles10.1002/mabi.201000125 ↗
11. Synthesis and characterization of dextran ester derivatives and their adhesive properties10.1186/s10086-019-1845-x ↗
12. Dextran: A promising macromolecular drug carrier10.4103/0250-474X.31000 ↗
13. Dextran conjugates in drug delivery10.1517/17425247.2012.673580 ↗
14. Effects of esterification on the structural, physicochemical, and flocculation properties of dextran10.1016/j.carbpol.2017.07.034 ↗
15. Meltable dextran esters as biocompatible and functional coating materials10.1021/bm200841b ↗
16. Amphipathic dextran-doxorubicin prodrug micelles for solid tumor therapy10.1016/j.colsurfb.2017.06.023 ↗
17. Dextran and the prevention of postoperative thromboembolic complications10.1016/S0039-6109(16)40642-0 ↗
18. Clinical pharmacokinetic considerations in the use of plasma expanders10.2165/00003088-198712020-00003 ↗
19. Anaphylactoid reactions to dextran 40 and 70: Reports to the United States Food and Drug Administration, 1969 to 200410.1016/j.jvs.2006.01.006 ↗
20. Colloid solutions for fluid resuscitation
21. In vitro evaluation of the effect of haemodilution with dextran 40 on coagulation profile as meas-ured by thromboelastometry and multiple electrode aggregometry10.1177/0310057X1704500506 ↗
22. Effect of dextran-70 on outcome in severe sepsis; a propensity-score matching study10.1186/s13049-017-0413-x ↗
23. Beth, H., Christopher, S., and Hillyer, D. (2019). Morayma Reyes Gil, Transfusion Medicine and Hemostasis, Elsevier. [3rd ed.].
24. Herndon, D.N., and Saunders, W.B. (2012). Total Burn Care, Elsevier. [4th ed.].
25. Recent advances in dextran-based drug delivery systems: From fabrication strategies to applications10.1016/j.carbpol.2021.117999 ↗
26. Current status and future prospects of bioactive molecules delivered through sustainable encapsulation techniques for food fortification10.1039/D3FB00015J ↗
27. Preparation of bioactive polysaccharide nanoparticles with enhanced radical scavenging activity and antimicrobial activity10.1021/acs.jafc.8b00388 ↗
28. Luo, Y. (2020). Food colloids binary and ternary complexes: Innovations and discoveries. Colloids Surf. B Biointerfaces, 196.10.1016/j.colsurfb.2020.111309 ↗
29. Physicochemical stability and in vitro bioaccessibility of β-carotene nanoemulsions stabilized with whey protein-dextran conjugates10.1016/j.foodhyd.2016.09.008 ↗
30. Saccharide-based nanocarriers for targeted therapeutic and diagnostic applications10.1002/pi.5702 ↗
31. Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells10.1016/j.ijbiomac.2016.03.040 ↗
32. In vivo biocompatibility of dextran-based hydrogels10.1002/(SICI)1097-4636(20000605)50:3<397::AID-JBM14>3.0.CO;2-A ↗
33. In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films10.1016/S0142-9612(98)00049-0 ↗
34. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues10.1016/j.addr.2008.11.002 ↗
35. Mucus penetrating nanoparticles: Biophysical tool and method of drug and gene delivery10.1002/adma.201201800 ↗
36. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin10.1021/acsnano.5b00028 ↗
37. Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin10.1016/j.ijpharm.2018.11.055 ↗
38. Nanoparticles in cancer treatment: Opportunities and obstacles10.2174/1389450119666180326122831 ↗
39. Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects10.1021/bc100070g ↗
40. Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity10.2147/IJN.S161203 ↗
41. Acid-responsive dextran-based therapeutic nanoplatforms for photodynamic-chemotherapy against multidrug resistance10.1016/j.ijbiomac.2020.03.197 ↗
42. Schiff base-containing dextran nanogel as pH-sensitive drug delivery system of doxorubicin: Synthesis and characterization10.1177/0885328218783969 ↗
43. A virus-mimicking pH-Responsive acetalated dextran-based membrane-active polymeric nanoparticle for intracellular delivery of antitumor therapeutics10.1002/adfm.201905352 ↗
44. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin10.1016/j.biomaterials.2017.03.028 ↗
45. Recent advances of polysaccharide-based nanoparticles for oral insulin delivery10.1016/j.ijbiomac.2018.08.152 ↗
46. Dextran-b-poly (lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation10.1016/j.jconrel.2016.02.031 ↗
47. New glucose oxidase-immobilized stimuli-responsive dextran nanoparticles for insulin delivery10.1016/j.ijbiomac.2018.11.147 ↗
48. Synthesis of methylprednisolone loaded ibuprofen modified dextran based nanoparticles and their application for drug delivery in acute spinal cord injury10.18632/oncotarget.20649 ↗
49. Dextran-based biodegradable nanoparticles: An alternative and convenient strategy for treatment of traumatic spinal cord injury10.2147/IJN.S171925 ↗
50. Direct synthesis of dextran-based antibacterial hydrogels for extended release of biocides and eradication of topical biofilms10.1021/acsami.7b03208 ↗
51. Chitosan–Iron oxide coated graphene oxide nanocomposite hydrogel: A robust and soft antimicrobial biofilm10.1021/acsami.6b07510 ↗
52. A photopolymerized antimicrobial hydrogel coating derived from epsilon-poly-L-lysine10.1016/j.biomaterials.2010.12.040 ↗
53. Poly (ethylene glycol)-based hyperbranched polymer from RAFT and its application as a silver-sulfadiazine-loaded antibacterial hydrogel in wound care10.1021/acsami.6b11371 ↗
54. Recent developments in the biosynthesis and applications of heteropolysaccharides from lactic acid bacteria10.1016/S0958-6946(01)00114-5 ↗
55. Torino, M.I., de Valdez, G.F., and Mozzi, F. (2015). Biopolymers from lactic acid bacteria. Novel applications in foods and beverages. Front. Microbiol., 11.10.3389/fmicb.2015.00834 ↗
56. Homopolysaccharides from lactic acid bacteria10.1016/S0958-6946(01)00113-3 ↗
57. Enzymatically synthesized dextran nanoparticles and their use as carriers for nutraceuticals10.1039/C4FO00103F ↗
58. Dextran-The polysaccharide with versatile uses
59. Influence of dextran-producing Weissella cibaria on baking properties and sensory profile of gluten-free and wheat breads10.1016/j.ijfoodmicro.2013.11.015 ↗
60. Klemm, D. (2006). Polysaccharides II, Springer.10.1007/11776895 ↗
61. Characterization and potential applications of high molecular weight dextran produced by Leuconostoc mesenteroides AA110.1016/j.carbpol.2011.08.094 ↗
62. Películas comestibles a base de un biopolímero tipo dextrana Edible films based of dextran biopolymer
63. Dextran/chitosan blend film fabrication for bio-packaging of mushrooms (Agaricus bisporus)
64. In vitro fermentation of linear and -1,2-branched Dextrans by the human Fecal microbiota10.1128/AEM.02568-10 ↗
65. The prebiotic effect of -1,2 branched, low molecular weight dextran in the batch and continuous faecal fermentation system10.1016/j.jff.2013.09.015 ↗
66. Exploring endophytes for in vitro synthesis of bioactive compounds similar to metabolites produced in vivo by host plants10.3934/microbiol.2021012 ↗
67. Biosynthesis of polyglutamic acid (γ-PGA), a biodegradable and economical polyamide biopolymer for industrial applications10.1016/B978-0-12-820084-1.00026-0 ↗
68. Dahiya, D., and Nigam, P.S. (2022). Clinical Potential of Microbial Strains, Used in Fermentation for Probiotic Food, Beverages and in Synbiotic Supplements, as Psychobiotics for Cognitive Treatment through Gut-Brain Signaling. Microorganisms, 10.10.3390/microorganisms10091687 ↗
69. Dahiya, D., and Nigam, P.S. (2022). Probiotics, Prebiotics, Synbiotics, and Fermented Foods as Potential Biotics in Nutrition Improving Health via Microbiome- Gut-Brain Axis. Fermentation, 8.10.3390/fermentation8070303 ↗
70. Dahiya, D., and Nigam, P.S. (2023). Antibiotic-Therapy-Induced Gut Dysbiosis Affecting Gut Microbiota—Brain Axis and Cognition: Restoration by Intake of Probiotics and Synbiotics. Int. J. Mol. Sci., 24.10.3390/ijms24043074 ↗
71. Dahiya, D., Manuel, J., and Nigam, P.S. (2021). An Overview of Bioprocesses Employing Specifically Selected Microbial Catalysts for γ-Aminobutyric Acid Production. Microorganisms, 9.10.3390/microorganisms9122457 ↗
72. Perspectives on the biotechnological production and potential applications of lactosucrose: A review10.1016/j.jff.2015.09.014 ↗
73. Structural analysis and characterization of dextran produced by wild and mutant strains of Leuconostoc mesenteroides10.1016/j.carbpol.2013.08.004 ↗
74. Structural characterization and rheological properties of dextran produced by native strains isolated of Agave salmiana10.1016/j.foodhyd.2018.11.052 ↗
75. BeMiller, J.N., and Whistler, R.L. (2012). Industrial Gums: Polysaccharides and Their Derivatives, Academic Press.
76. Characterization of dextrans produced by Lactobacillus mali CUPV271 and Leuconostoc carnosum CUPV41110.1016/j.foodhyd.2018.10.053 ↗
77. Physicochemical characteristics of a high molecular weight bioengineered-D-glucan from Leuconostoc citreum SK24.00210.1016/j.foodhyd.2015.04.009 ↗
78. Fermentative production of dextran using Leuconostoc spp. isolated from fermented food products10.1007/s11515-014-1303-5 ↗
79. Statistical optimization of media for dextran production by Leuconostoc sp. isolated from fermented Idli batter10.1007/s10068-010-0066-2 ↗
80. Structural characterization of insoluble dextran produced by Leuconostoc mesenteroides NRRL B-1149 in the presence of maltose
81. Biosíntesis de dextranos de alto peso molecular mediante la inoculación con Leuconostoc síntesis y caracterización de hierro-dextranos
82. Dextran synthesized by Leuconostoc mesenteroides BD1710 in tomato juice supplemented with sucrose10.1016/j.carbpol.2014.06.035 ↗
83. Production and structural characterisation of dextran from an indigenous strain of Leuconostoc mesenteroides BA08 in whey10.1111/1471-0307.12271 ↗
84. Rheology and bioactivity of high molecular weight dextrans synthesised by lactic acid bacteria10.1016/j.carbpol.2017.06.113 ↗
85. Fermentative production of dextran using food industry wastes
86. Esmaeilnejad-Moghadam, B., Mokarram, R.R., Hejazi, M.A., Khiabani, M.S., and Keivaninahr, F. (2019). Low molecular weight dextran production by Leuconostoc mesenteroides strains: Optimization of a new culture medium and the rheological assessments. Bioact. Carbohydr. Diet. Fibre, 18.10.1016/j.bcdf.2019.100181 ↗
87. Prechtl, R.M., Janßen, D., Behr, J., Ludwig, C., Küster, B., Vogel, R.F., and Jakob, F. (2018). Sucrose-induced proteomic response and carbohydrate utilization of lactobacillus sakei TMW 1.411 during dextran formation. Front. Microbiol., 9.10.3389/fmicb.2018.02796 ↗
88. Optimization and statistical evaluation of medium components affecting dextran and dextransucrase production by Lactobacillus acidophilus ST76480. 01
89. Characterization and biocompatibility of glucan: A safe food additive from probiotic Lactobacillus plantarum DM510.1002/jsfa.6305 ↗
90. The production of glucans via glucansucrases from Lactobacillus satsumensis isolated from a fermented beverage starter culture10.1007/s00253-012-4606-y ↗
91. Production of dextran from locally Lactobacillus spp. isolates
92. Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen10.1073/pnas.172501299 ↗
93. Characterization of glucansucrase and dextran from Weissella sp. TN610 with potential as safe food additives10.1016/j.ijbiomac.2012.09.014 ↗
94. Biosynthesis of dextran by Weissella confusa and its In vitro functional characteristics10.1016/j.ijbiomac.2017.10.048 ↗
95. Syneresis rate, water distribution, and microstructure of wheat starch gel during freeze-thaw process: Role of a high molecular weight dextran produced by Weissella confusa QS813 from traditional sourdough10.1094/CCHEM-08-17-0174-R ↗
96. Characterization and rheological behavior of dextran from Weissella confusa R00310.1155/2018/5790526 ↗
97. Characterization of exopolysaccharide and ropy capsular polysaccharide formation by Weissella10.1016/j.fm.2014.08.022 ↗
98. Dextran-like exopolysaccharide-producing Leuconostoc and Weissella from kimchi and its ingredients10.1007/s10068-013-0182-x ↗
99. Production, characterization and antibacterial activity of exopolysaccharide from a newly isolated Weissella cibaria under sucrose effect10.1016/j.jbiosc.2018.05.028 ↗
100. Structural and biocompatibility properties of dextran from Weissella cibaria JAG8 as food additive10.3109/09637486.2014.917147 ↗